Aptus Endosystems, a developer of endovascular aneurysm repair (EVAR) technology, has completed $25m series BB equity financing. Aptus will use the finance to expand commercialization of its HeliFX Aortic Securement system in the US and ...
Tags: Aptus Endosystems, endovascular aneurysm repair technology
Roche has announced the US launch of automated Elecsys HE4 assay, designed as an aid in monitoring the recurrence or progressive disease in patients with epithelial ovarian cancer. The assay, which is approved for use on the Elecsys ...
Tags: epithelial ovarian cancer, clinical technology, clinical trial
Cartiva, a developer of orthopedic implants, has completed enrolling patients in its MOTION trial. The prospective, multi-center trial, which has enrolled 233 patients across Canada and the UK, is designed to assess the company's ...
Tags: Cartiva, clinical trial, clinical technology
Boston Scientific has completed enrolling first patient in REPRISE II clinical trial, designed to assess the safety and efficacy of the Lotus Valve system in minimizing aortic regurgitation (leaking). The Lotus Valve system, which the ...
Tags: Boston Scientific, first patient, REPRISE II clinical trial
W. L. Gore & Associates has completed enrolling first patient in a clinical trial of its GORE Septal Occluder, designed for the percutaneous, trancatheter closure of ostium secundum atrial septal defect (ASD). The device features a ...
Tags: Gore, first patient, clinical trial, Septal Occluder, ASD
Medtronic has completed enrolling patients in a clinical trial of its Amphirion drug-eluting balloon, designed to treat critical limb ischemia. The CE-marked Amphirion drug-eluting balloon features proprietary FreePac proprietary ...
Tags: Medtronic, clinical trial, limb ischemia, Amphirion drug-eluting balloon
Handsome in South Manchester, UK, has received £250,000 from The North West Fund for Biomedical, managed by SPARK Impact. Handsome will use the capital to complete product development and clinical trial studies as well as achieve ...
Tags: spinal pain, Biomedical, clinical trial studies, healthcare
Medtronic has begun its minimally invasive Symplicity renal denervation system's clinical trial in Japan to treat patients who are not responding to different types of anti-hypertensive medications and are at risk of stroke. The ...
Cohera Medical has gained investigational device exemption (IDE) from the US Food and Drug Administration (FDA) to commence the first no-drain clinical trial of its internal surgical adhesive. Designed for use during abdominoplasty ...
Tags: Cohera Medical, Cohera, Surgical Adhesive, surgeries
Vascular Nanotransfer Technologies has reported in vivo test results of its paclitaxel nanocarrier-based Drug Coated Balloon (DCB) technology, designed for patients with coronary in-stent restenosis and peripheral vascular disease. ...
Tags: Drug Coated Balloon, medical technology, clinical trial
NorthShore University HealthSystem has used Amyvid (Florbetapir F 18 Injection) radioactive diagnostic agent to evaluate patients for Alzheimer's disease. The diagnostic agent, approved for positron emission tomography (PET) imaging ...
Tags: clinical trial, Alzheimer's disease, positron emission tomography
Delcath Systems has submitted its proprietary chemosaturation delivery system's new drug application (NDA) to the US Food and Drug Administration (FDA). The application includes the use of chemosaturation system along with melphalan ...
Tags: FDA, NDA, medical application
CellAegis Devices has obtained Health Canada's investigational testing (ITA) approval to initiate a pilot clinical trial of its noninvasive autoRIC device for remote ischemic conditioning (RIC). The CE-marked device is placed around ...
Tags: Health Canada, ITA, clinical trial, RIC
Boulder Diagnostics, a developer of new diagnostic technologies, has launched Lyme Borreliosis disease test as a diagnostic service in Europe. The SpiroFind test, which is offered by the company's clinical diagnostic service ...
Tags: clinical trial, diagnostic technology, Boulder Diagnostics
Health Canada has approved Roche's fully automated test, designed to assess a patient's viral load of cytomegalovirus (CMV). The COBAS AmpliPrep / COBAS TaqMan CMV assay is the first approved test, which is standardized to the WHO ...
Tags: Health Canada, CMV, clinical trial